Physician profile
John L Ditto
NPI 1083732325
$3,581.96
in general payments reported to CMS, 2019-2025
19 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $203 · 2021: $870 · 2022: $985 · 2023: $552 · 2024: $351 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.09 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $655.89 | 2020-2025 | |
| Intersect Ent, INC. | $635.45 | 2019-2022 | |
| Genzyme Corporation | $556.08 | 2020-2025 | |
| Glaxosmithkline, LLC. | $541.38 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $271.49 | 2020-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $195.49 | 2022-2023 | |
| Alk-Abello, INC | $152.71 | 2020-2023 | Odactra, Ragwitek, Grastek |
| Stryker Corporation | $103.96 | 2020-2022 | |
| Phadia US INC. | $86.70 | 2019-2023 | Immunocap |
| Medtronic, INC. | $85.16 | 2022-2023 | Propel |
| Astrazeneca Pharmaceuticals Lp | $84.05 | 2019 | |
| Paratek Pharmaceuticals, INC. | $58.66 | 2025 | Xhance |
| Olympus America INC. | $43.84 | 2019-2022 | |
| Karl Storz Endoscopy-America | $20.59 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.82 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $19.37 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Tactile Systems Technology INC | $18.52 | 2020 | |
| Medtronic USA, INC. | $18.04 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $14.76 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ditto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.